Data story: India logs 1,574 new Covid cases; death toll at 529,008

India has added 9,914 cases in the past 7 days

Covid test, coronavirus
India on October 28 conducted 165,901 coronavirus tests
Business Standard New Delhi
2 min read Last Updated : Oct 29 2022 | 1:04 PM IST
India on October 29 reported a fall of 596 in active coronavirus cases taking the count to 18,802. The country is fiftieth among the most affected countries globally by active cases. On October 29, it added 1,574 cases to take its total caseload to 44,650,662. And, with 9 new deaths, including five fatalities reconciled by Kerala, its Covid-19 death toll reached 529,008, or 1.18 per cent of total confirmed infections.
 
With 172,838 more Covid-19 vaccine doses being administered on October 28, India’s total count of vaccine shots so far has reached 2,196,218,338. The count of recovered coronavirus cases across India, meanwhile, reached 44,102,852 — or 98.77 per cent of the total caseload — with 2,161 cured cases being reported on October 29.

India has added 9,914 cases in the past 7 days.
India has so far administered 2,196,218,338 vaccine doses.
The count of active cases across India on October 29 saw a decrease of 569, compared with 1,423 on October 28.
With 2,161 new daily recoveries, India’s recovery rate stands at 98.77%, while the fatality rate is at 1.18%.
India’s new daily closed cases stand at 2,170— 9 deaths and 2,161 recoveries.
India on October 28 conducted 165,901 coronavirus tests to take the total count of tests conducted so far in the country to 9,00725,697.
The five most affected states by total cases are Maharashtra (81,31,139), Kerala (6,821,230), Karnataka (40,68,558), Tamil Nadu (3,591,571), and Andhra Pradesh (2,338,889).
The five states with the most active cases are Kerala (3,402), Assam (2,621), Tamil Nadu (2,114), Karnataka (1,944), and Maharashtra (1,621).
The five states with the highest fatalities are Maharashtra (148,383), Kerala (71,375), Karnataka (40,296), Tamil Nadu (38,048), and Delhi (26,508).
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCovid-19 XE VariantDelta variant of coronavirusOmicronHerd ImmunityCommunity TransmissionICMRHealth MinistryhealthcareHealth crisisDeath tollCoronavirus VaccineCoronavirus Tests

Next Story